ランセットの女性と心血管疾患委員会: 2030年までに世界の負担を軽減する
Birgit Vogel1, Monica Acevedo2, Yolande Appelman3
1Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Lancet (London, England)
|May 19, 2021
まとめ
心血管疾患は 啓発キャンペーンにも関わらず 女性にとって大きな健康問題です 2030年までに世界の女性における心臓病の負担を減らすために,知識のギャップと格差を解決することが不可欠です.
科学分野:
- 心臓病科
- 女性 の 健康
- 公衆衛生
背景:
- 心血管疾患 (CVD) は,世界的に女性の死亡の主な原因です.
- 認知度が上がっているにも関わらず 女性のCVDの負担を減らすための進歩は 過去10年間で停滞しています
- 女性のCVDの特徴は 認知不足,診断不足,治療不足です
研究 の 目的:
- 女性の心血管疾患に関する現在の証拠をまとめます
- 研究,予防,治療,ケアへのアクセスにおける重大な知識のギャップを特定する.
- 2030年までに女性におけるCVDの世界的な負担を軽減することを目的とした専門家による勧告を提供すること.
主な方法:
- 既存の証拠の包括的な見直し
- 研究,予防,治療,ケアへのアクセスにおける知識のギャップを特定する.
- 国際専門家パネルによる勧告の作成
主要な成果:
- 女性の心臓血管疾患の研究,診断,治療において 顕著な格差が続いている.
- 性別やジェンダーに特化した心血管疾患の治療方法が不可欠です
- 委員会は,意識向上努力にもかかわらず,心血管疾患の負担を減らすという停滞を強調しています.
結論:
- 女性の心臓血管疾患は 継続的な課題を克服するために 緊急で集中的な注意が必要です
- 効果的な予防と治療戦略には 性別やジェンダーの差異に対処することが不可欠です.
- この委員会は,女性の心臓血管の健康を改善するための世界的な行動と将来の研究のための触媒として機能します.
さらに関連する動画
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
4.1K
03:35Determining Gender-Based Differences in Retinal and Choroidal Thickness in Underweight Individuals via Swept-Source Optical Coherence Tomography
Published on: December 1, 2023
428
関連する概念動画
01:17Ischemic Heart Disease: Overview
3.8K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.8K
01:30Coronary Artery Disease I: Introduction
1.8K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
01:26Coronary Artery Disease IV: Preventive Measures
890
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
01:28Acute Coronary Syndrome IV: Interprofessional Care
522
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
522
01:26Atherosclerosis III: Management
741
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
01:27Peripheral Artery Disease III: Interprofessional Care
655
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
655